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7.1 INTRODUCTION Introduction
This thesis presents a series of studies analyzing the sourcesused by journalists when writing about medicines. The main
question addressed was: Which sources are used and for what rea-
son? The underlying concern was if the mass media can be consid-
ered a good channel in optimizing rational drug use. In this final
chapter the results are discussed after making some remarks about
the methods used.
7.2 SOME NOTES ON THE METHODS Some Notes on the Methods
In this study the approach has been qualitative because it is ex-ploratory and qualitative methods are well suited in this type of
study. In particular, if the study explores the meanings, variations,
and perceptual experiences of phenomena qualitative methods are
the instruments of first choice [1].
The qualitative approach (in depth interviews) was combined
with a quantitative approach (content analysis). Qualitative and
quantitative methods can be effectively used in the same research
project [2]. We used the quantitative data obtained from the con-
tent analysis to validate the qualitative data on some topics from
the interviews. This use of multiple data sources, and of multiple
methods as well as the use of various records is called triangula-
tion [3]. The combination of a quantitative and qualitative ap-
proach should be used more often in this field of research. As
shown in this thesis, the differing research approaches provide us
with complementary information. It has been very useful in the
understanding of the process of making news about medicines. In
chapter 4, for example, the interviews provided information on the
selection of experts in general; the content analysis showed that
journalists differentiate between researchers and functional ex-
perts on one hand, and spokespeople from pharmaceutical compa-
nies, patients’ interests groups and patients on the other hand.  
The methods most commonly used to study the sources used by
science journalists are direct questioning the journalists them-
selves in interviews or by using mail questionnaires or a combina-
tion of both methods. Examples of these approaches can be found
in the study of Stappers et al. in the Netherlands [4] and the study
of Winnubst in Belgium [5], looking into the sources used by sci-
ence journalists. They used structured questionnaires and ques-
tions with "fixed" answers, i.e. quantitative approaches, directed at
answering questions like, for example, how many journalists use
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the scientific literature as a source of information. Disadvantages
of using a quantitative approach in studying the sources used by
journalists are that one needs to know beforehand what sources
can be used and that the kind of questioning can influence the an-
swers of the respondents and as such introducing a form of bias
[6]. 
In depth interviews
In qualitative research the number of respondents is small com-
pared to the sample size in quantitative research. Sample size is
not the determinant of research significance in a qualitative study.
The aim is to illuminate the research question, and the major con-
cern is with information richness [7]. The respondents interviewed
in this thesis were, in case of newspapers and family magazines,
the journalists responsible for news about medicines, except for
news about drug policy. To illuminate the role of the pharmaceuti-
cal industry, the persons responsible for the contacts with the
press were interviewed. The studies described in this thesis show
that interviews with a small number of respondents provide us
with in depth information on several topics relevant in the process
of making news about medicines. 
The issue of generalizability is raised frequently in critics of
qualitative research [7]. In case of our study this problem is less
relevant since the journalists interviewed have a great coverage.
The circulation of the daily newspapers, which the journalists in-
cluded in this study work for, accounts for approximately 42% of
all Dutch newspapers [8]. These newspapers sell about 2 million
copies, so the journalists are responsible for articles on medicines
which can be read by a large part of the Dutch population. The
same is true for the magazines. The total circulation of the three
women’s magazines of which the journalists were interviewed in
this study is 1.430.000 copies weekly. The magazine with the larg-
est circulation prints over 740.000 copies every week and reaches
32% of the Dutch population and 50% of the women in the Neth-
erlands over 13 years old [9]. Both the newspaper journalists and
the family magazine journalists may play a major role in informing
a general public about medicines. 
A disadvantage of using (in depth) interviews is the possibility
of social desirable answers, i.e. answers biased by the respondent’s
attempt to give answers that are socially desirable or preferred. To
deal with this problem we guaranteed, of course, the anonymity of
all our respondents both the journalists and the public relations of-
ficers from the pharmaceutical companies. Secondly, in the inter-
views with the journalists, check or control questions were used;
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some questions were asked twice in a different way at another mo-
ments of the interview.
All the interviews were tape-recorded and fully transcribed. The
tape-recording of the interviews was necessary because many
open-ended questions were asked; writing the answers down can
cause uncomfortable delay in the interview. Because we used
semi-structured in depth interviews the transcripts were very use-
ful for combining relevant information on the different research
questions coming up - sometimes even unasked - in different parts
of the interviews. A technical problem of method used is that it is
very time-consuming.
Content analysis
Content analysis is a research technique for the objective, system-
atic, and quantitative description of the manifest content of com-
munication [10]. We used this technique in our studies on the
sources (chapter 2 and 6), the study on the agenda-setting function
of the scientific and medical literature (chapter 3) and the study on
the role of experts (chapter 4). The main problem of content analy-
sis is objectivity of the coders. Since communication always in-
cludes the encoding of a message by the sender - in this case, for
example, the journalist - and the decoding by the receiver - this
case the coder - subjective interpretation cannot be avoided [10].
To deal with possible inconsistency of classification all the analyses
were done twice, at least once by the author of this thesis.  
The combination of in depth interviews and content analysis 
In general, the results of the interviews with respect to the sources
seem to be confirmed by the results of the content analysis. How-
ever, a few remarks have to be made about this comparison. The
comparison at the level of the information sources is not com-
pletely exact because, as indicated by the journalists, not all the in-
formation sources are always mentioned in the articles.
Understandably, only the most important sources and the most in-
fluential ones are mentioned. The source may make a story news-
worthy; it is possible that sources like the New England Journal of
Medicine are overrepresented in the content analysis. Whenever
this journal is used it is mentioned in an article; this is less prone to
occur with a Dutch journal, which may be considered to be less
authoritative. 
The difference found regarding the role of the pharmaceutical
industry as a source of information (see chapter 2), between the re-
sults of the content analysis and the interviews  may have been
due to the way the pharmaceutical industry was coded in the con-
Chapter 7
102     Some Notes on the Methods
tent analysis. On the other hand this difference may have been
caused by socially desirable answers in the interviews. 
Better insight in the role of the pharmaceutical industry as a
source of ideas and information for newspaper journalists needs
further research. To overcome the difficulties of an interview with
its inherent possibility of bias, one could envisage a study in which
all the material available to journalists from universities, pharma-
ceutical companies and other sources is analyzed and compared to
newspaper articles that appear during that period. Another possi-
bility is a study in which medical journalists are observed during
their work. Such work has been undertaken in another field of
journalism by Gans [11], but it is clearly labour-intensive and time-
consuming. In chapter 5 we used another approach to gain insight
in the role of the pharmaceutical industry as a source of ideas and
information, we interviewed public relation officers from pharma-
ceutical companies about the way they make use of mass media
channels and the manner in which they approach mass media
journalists. The results of these interviews showed that a company
does not approach journalists often, but there are many companies
approaching mass media journalists with information about their
products or their company. The content analysis shows that phar-
maceutical companies are often mentioned as sources of informa-
tion (see chapter 2).
7.2 SOURCES FOR NEWSPAPER JOURNALISTS
 DIFFERENT ROLES Sources for newspaper journalists: different roles
Most studies on the sources of science journalists have concen-trated on which information sources are being used. In the
agenda-setting theory another function of sources is described. A
source may not be successful in telling the audience what to think
about a certain topic but may be successful in telling the the audi-
ence what topics to think about [12]; in other words to be a source
of ideas. Our hypothesis is that journalists can use the sources in
two ways, as a source of ideas or as a source of information. A
source of ideas is a source which plays an important role in the se-
lection of a topic to write about. A source of information is used by
a journalist to write his story, to obtain (extra) information on the
already selected topic. The way in which a source is used, as a
source of ideas or information, influences the content of media re-
porting in a different way. Because we are interested in the factors
influencing the content of media reporting on medicines we differ-
entiated between these two kinds of sources.
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Our hypothesis that sources can fulfil different functions was
confirmed in our study. Some sources are more important as
sources of ideas while others are more important as sources of in-
formation. The results of our study are summarized in figure 1.
Agenda-setting
Our findings that the drugs most often discussed in the scientific
and medical literature also appear in the mass media suggests the
agenda-setting role of these journals (chapter 3). Vice versa, the
scientific and medical community may also use the daily newspa-
pers as an initial source. As shown by Philips et al., scientific arti-
cles from the New England Journal of Medicine which had been
covered by the New York Times were more often cited in other sci-
entific articles than articles not covered by the Times[13]. We as-
sume that the article in the New York Times did not contain enough
information for scientists but alerted them to the original article in
the New England Journal of Medicine. Also in this example we can
distinguish between the source of idea, in this case the New York
Times, and the source of information, the New England Journal of
Medicine, as used by the scientist.
However, the agenda-setting function of the scientific and
medical literature seems to apply less to "bad news", articles focus-
ing on side effects of drugs. Whereas the "good news" agenda of
the scientific and medical literature is comparable to the "good
news" agenda of the newspapers, the "bad news" agendas, on the
other hand, are quite different. It seems that in the case of "bad
news" other sources of ideas are more important. Different sources
Figure 1
Sources of ideas and of information used by newspaper journalists.
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might supply journalists with information on unexpected side ef-
fects of medication or other information important to the users of a
particular drug, like for example in the case of acitretin. Both the
company selling acitretin and the authorities sent letters to all
health professionals and, in addition, sent a press release to the
mass media and the mass media did pay attention to the acitretin
problem [14]. In case of triazolam, a Dutch psychiatrist informed
the mass media about his observation of serious side-effects
[15,16]. Different sources can thus fulfil the agenda-setting role
with respect to "bad news".
The relationship between journalists and the scientific
and medical community
Information from the scientific and medical community comes
through different channels to mass media journalists. These differ-
ent channels appear to fulfil different functions. Press releases
from universities are only important as a source of ideas. Press re-
leases draw the attention of a journalist to a topic but seldom con-
tain enough information to be used as sources of information.
Experts are used as sources of information. The scientific and
medical literature is important both as a source of ideas and infor-
mation. Journalists subscribe to certain scientific journals, they
chose themselves, to look for "safe" subjects to write about and for
valid information. The information in these journals is usually
peer-reviewed, and gives the journalists, therefore, some guaran-
tee about the correctness and reliability of the information given.
According to Entwistle, British medical journalists rely on medical
journals for the same reason [17]. The journalists seem to use the
same standards and codes as those used in the scientific commu-
nity to judge the significance of research. This might be explained
by the fact that they are dependent on experts from the scientific
community for information. If one makes mistakes this might have
consequences for one’s relationship with informants or experts.
And secondly, all journalists are aware of the fact that news about
medicines might create false hopes. They all claim to be very care-
ful when writing about medicine(s). One way to be very careful is
to only use information that is considered to be valuable within
the scientific community and, therefore, published in "quality"
journals.
The "Buck affair"
As already discussed, journalists seem to differentiate between two
kinds of information sources. This differentiation is also shown in
chapter 4 in which we studied the role of different experts as
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sources of information. Objective sources are, for example, re-
searchers and medical and scientific journals, whereas the phar-
maceutical industry and patients can be considered as subjective
sources. An objective source can be the sole source used to write
an article on medicines, whereas subjective sources are seldom the
only source used. The newspaper journalists recognize the risk of
obtaining one-sided information or even incorrect information us-
ing one source, objective or subjective, and have learned their les-
son from the affair with professor Buck. This affair shows what can
go wrong.
In April 1990 professor Buck and his colleagues announced at a
press conference a major breakthrough in the AIDS research. The
mass media paid much attention to these remarkable findings. The
day after this press conference the results were published in Sci-
ence and therefore journalists thought the findings were reliable.
However, later that month, there were doubts about the stability
and purity of the substance used in the experiments. A year later, a
research committee observed shortcomings and mistakes in the
planning of the research, the interpretation of the results and their
presentation in the Science article. 
All sorts of people, including scientific researchers, do want to
get their messages out through the newspapers for all sorts of rea-
sons, and they may not be as careful as they should be [18]. Partly
in response to the Buck affair Dutch biomedical researchers devel-
oped a concept code of conduct with respect to press contacts. In
this code it is stated that researchers should be very careful in giv-
ing information to mass media journalists to prevent that their
statements create false hope or unnecessary fear. Before notifying
the press about developments they should discuss the results of
their research with their peers [19]. 
Both journalists and researchers should be very careful with in-
formation about research findings which could possibly lead to
new cures for life threatening diseases or untreatable diseases.
Journalists should use their common sense to evaluate research
findings, even if these findings are peer reviewed and published in
scientific journals, and ask experts for advice. Researchers should
evaluate their own research findings and those of other re-
searchers very critically. Despite the fact that both researchers and
journalists agree to be as careful as they can, the Buck affair can
happen again.
Chapter 7
106     Sources for newspaper journalists: different roles
Controversies: Prozac ®
In chapter 4 we showed that different experts cited in the same ar-
ticle most of the time gave the same or complementary informa-
tion. This is in contrast with, for example, political reporting,
where experts are used to express different views in the same arti-
cle. In the field of medicine, the media seem to exclude dissident
experts and voices [20]. However, in some cases different views
are expressed. In recent years, the mass media in the Netherlands
did pay much attention to the different views about fluoxetine
(Prozac®). Some of the reports regard this drug as a breakthrough
in psychiatric treatment while others do not think fluoxetine to be
different from the other drugs used in psychiatry. Furthermore,
there is a debate going on amongst the advocates and opponents
of the biological psychiatry or psychopharmacology. The advo-
cates argue that psychiatric disorders are caused by too much or
too little neurotransmitters and can be treated by drugs influenc-
ing neurotransmitters. The opponents, on the other hand, chal-
lenge this theory and propose other therapeutic measures, like, for
example, counselling therapy. 
During our study-period attention was paid to different views.
A small number of articles was dedicated to fluoxetine; according
to the Scientology Church fluoxetine caused suicide and this drug
should not be used, while on the other hand psychiatrists claimed
that not fluoxetine but the depression fluoxetine was used for, was
the cause of the suicide. In the mean time, Jick et al. have showed
that the risk of suicide is not determined by the antidepressant
used. They state that, though the suggestion has been made that
fluoxetine may trigger an emotional state which in itself increase
the risk of suicide, this suggestion can not be supported by formal
evidence [21]. 
"Objective" versus "Subjective" sources
Physicians and medical researchers (objective sources) are treated
differently by the media than other sources of information. Karpf
states that when doctors and medical researchers take part in radio
or TV programmes they are accorded privileges which would turn
politicians green with envy. When an interview is recorded, sci-
ence features producers and presenters are generally keen to en-
sure that a scientist or doctor has expressed himself in the best
possible way, and both sides are satisfied with the result. Though
broadcasting organisations formally retain editorial control, doc-
tors and scientists are often allowed to view programmes before
transmission and suggest editorial changes on the grounds of
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medical inaccuracy [20]. The situation in Britain as described by
Karpf cannot be confirmed in the Netherlands. Most of the news-
paper journalists in our study do not have such a strict policy re-
garding the "control" of the scientist or physician interviewed prior
to publication. When the expert interviewed wants to check the ar-
ticle this will be arranged, and whenever the journalist is not sure
that he has got the information right, then this would be another
reason to ask the expert to check it. During the correction process
only facts can be changed. These results are confirmed by Willems
et al. who also interviewed science journalists in the Netherlands
[22].
The "subjective" sources are treated differently by the journal-
ists. Spokespeople of pharmaceutical companies are usually not
asked to check the information they have given to the journalists. 
Patients are seldom used as sources of information by science
journalists writing about medicines in Dutch newspapers. It seems
that these journalists consider the expertise of one patient an in-
sufficient basis for an article. In society, however, the expertise of
patients is recognized to be important. Patients and interest groups
do play a role as experts in the development and implementation
of health policy. In our study period, patients were cited in news-
paper articles with respect to sumatriptan, which was introduced
during that period as a new drug for the treatment of migraine.
Migraine patients are, just like many other patient groups, well or-
ganized in an interest group. It is, for a journalist, relatively easy to
trace these patients while in the case of other diseases it might be
more difficult to find a patient who is willing to talk about his ex-
perience. More important is the fact that these journalists do not
consider patients to be experts. It is our impression that patients
and interest groups are more often used as sources of information
with regard to drug policy. In relation to the Dutch drug reim-
bursement system, introduced in the beginning of the 1990s, inter-
est groups were able to express their opinion in newspaper
articles. 
7.3 FAMILY MAGAZINES Family magazines
The sources of ideas and information used by journalists writingin family magazines are quite different as compared to those
used by newspaper journalists. Letters from readers and mass me-
dia channels are the most important sources of ideas. This agenda-
setting role of the newspapers is confirmed in our comparison of
the drugs most often discussed in the newspapers and those most
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often discussed in family magazines. This agenda-setting through
other mass media channels can take place in a direct and indirect
way. Direct, because the editors use other mass media as sources
of ideas. Indirect because some people write letters to the maga-
zine in response to mass media publicity. These letters from read-
ers on medical topics are important for the editors of family
magazines. They provide information about the topics that are
worthwhile discussing because readers have to deal with these
topics and are interested in them. Family magazines have to please
their readers; approximately 60% of the revenue comes from sub-
scriptions and the sale of single issues [23].
Experts, in particular general practitioners and medical special-
ists, and patients are the most important sources of information
(see figure 2). In contrast to our findings in newspapers, family
magazines prefer to use the same expert on several occasions. The
information needed from an expert is information of practical
value, not on the level of scientific research. Journalists working on
family magazines seem to prefer generalists and professionals "di-
rectly" caring for patients. Therefore, it is possible for these journal-
ists to use the same experts at different moments. It is sometimes
difficult to find another expert because not all experts are suitable
as sources of information. Often the magazines employ physicians
to answer the questions received from the readers of the maga-
zine. The pharmacist is seldom asked for advice, despite his exper-
tise and the fact that he is also more or less a generalist in the field
of medicines.
Another contrast to newspapers, is that patients are important
sources of information in family magazines. Readers of family
magazines learn from articles and the question and answer section
Figure 2
Sources of ideas and information used by ’family magazine’ journalists
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how others solve and deal with problems in the field of illness.
Furthermore readers are especially interested in human interest
stories and the question and answer section [24]. This being the
case it seems rational to use patients as sources of information.
Family magazines and pharmaceutical companies
Sometimes a magazine co-operates with a pharmaceutical com-
pany. A company may finance an enclosure about a disease or
group of drugs. Both the journalists and the spokespeople of phar-
maceutical companies mentioned this kind of co-operation. In this
case the magazine is financially dependent on the support of the
industry. Another form of dependence can arise if pharmaceutical
companies advertise in these magazines.
Kessler showed that women’s magazines in the United States
did not cover smoking-related health concerns because they might
risk losing advertising revenue by publishing articles on this sub-
ject. Still, women’ health was a major concern of all the magazines
[25]. The risk of losing advertisers can become a conflict of interest
between the editors and financial managers of a magazine. In 1981
the Dutch family magazine Nieuwe Revu published a ten page ar-
ticle on smoking and its hazards. The tobacco industry reacted
with an advertising stop [26]. Such a conflict of interest sometimes
influence the independency of the editorial board. Advertisements
are important to women’s magazines; about 40% of the revenue
originates from advertisers [23]. The pharmaceutical industry is
important in terms of OTC (over-the-counter) advertisements. This
can make the magazine dependent. Because the journalists also
use pharmaceutical companies as a source of information, this may
seriously bias the information provided.
Newspapers versus family magazines
The differences in sources used by newspaper journalists and fam-
ily magazine journalists can be explained by their differences in
function. Whereas newspapers focus on news, family magazines
are more interested in information that is directly useful or appli-
cable for their readers and not new information or news per se.
Family magazines are guided by letters from their readers and by
other mass media channels for the selection of topics that might be
of interest for their readers, whereas newspapers journalists writ-
ing about medicines, are guided by the scientific and medical com-
munity to get information on recent developments in the
pharmaceutical field. This may in part be explained by the type of
newspaper journalist we interviewed, medical or science journal-
ists. In our newspaper study, information on drug policy and the
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Dutch drug reimbursement system was excluded. The journalists
working on family magazines stated that drug policy and the re-
imbursement system were topics they never wrote about. 
These differences in function are also reflected in the sources of
information used. Newspapers seem to prefer scientific experts
whereas family magazines seem to prefer generalists and health
care professionals. Neither newspapers nor family magazines con-
sider the pharmacist important as a source of ideas or information.
The recommendation of the World Health Organization in 1989
that the pharmacist should play a central role in the provision of
advice and information to the general public on the use of medi-
cines has, therefore, not yet been implemented [27]
7.4 THE PHARMACEUTICAL INDUSTRY AND THE LAY PRESSThe pharmaceutical industry and the lay press
Information from the pharmaceutical industry to the general pub-lic has become more extensive and emphatic. Pharmaceutical
companies consider informing a lay audience about their products
and diseases to be important. In our study two reasons were given
to explain this increasing interest of pharmaceutical companies in
a lay audience: 1. the emancipation of patients; and 2. the weak
image of the pharmaceutical industry which has to be dealt with.
Because EC directives forbid the advertising of prescription drugs
to the general public [28] one sees that pharmaceutical companies
try to gain interest from the mass media journalists to pass on mes-
sages to a mass audience [29-33]. In our study the representatives
from pharmaceutical companies stated that the lay press, both
daily newspapers and family magazines,  play an important role in
informing a lay audience about diseases and (new) products obvi-
ously because of the great impact.
As long as independent and critical journalists and editors de-
cide themselves if information about drugs coming from pharma-
ceutical companies is newsworthy enough to be published it is
news and no "hidden advertising". Journalists should make it very
clear to the reader which sources have been used to write the arti-
cle, so that the receiver himself can decide whether or not the in-
formation is reliable. Journalists are aware of the fact that news
about (new) drugs might create false hopes and patients have no
choice whether or not to "buy" or use a particular drug.  Some
journalists feel responsible for the consequences or effects of their
publications [22]; this does not stop them to write about develop-
ments in AIDS research or potential new drugs. As stated above,
editors of magazines can become dependent on the pharmaceuti-
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cal industry because of the revenues of OTC advertisements and
financial support from companies to publish enclosures on certain
drugs or diseases. This may seriously bias the information pro-
vided. 
Sturkenboom et al. showed that the mass media do play an im-
portant role in warning the users of a prescription drug quickly,
and that not all the users can be traced and will be informed
through health professionals in the Netherlands [14]. In such a
case it is important that pharmaceutical companies and journalists
co-operate in the best and most effective way they can. Mass me-
dia play an important role in warning users of a drug quickly
whenever a major health threat is associated with that particular
drug. 
7.5 MASS MEDIA REPORTING AND THE PROFESSIONAL VIEWMass Media Reporting and the Professional View
Our study shows the scientific and medical community to bemajor sources of information on medicines used by newspa-
per journalists. These sources obviously have their reasons on
some occasions to inform the press about recent developments.
Sometimes researchers try to attract mass media publicity - before
publication in scientific or medical journals- because publicity
might influence research funding. Another reason to supply jour-
nalists with information about "unpublished" results is that rapid
dissemination of information about promising new therapies is
crucial for patients with severe illnesses that have no effective
treatment [34,35]. Steinbrook argues that only for a tiny minority
of studies, this urgency justifies unconventional communications
[34]. The public discussion of results after formal publication has
the advantage of peer review but introduces a delay of many
months [35]. We prefer media publicity after formal publication
and agree with Steinbrook, who states that editors of scientific
journals should accelerate reviews of studies of far-reaching clini-
cal significance [34]. Formal publications before mass media pub-
licity gives health professionals the opportunity to judge the
results of a study themselves. Mass media reports do not provide
health professionals with enough information to make a balanced
decision about, for example, a new drug. Mass media publicity can
accelerate the diffusion of information by pointing out to impor-
tant scientific papers. In case new information about unexpected
severe side effects of drugs becomes available or a life threatening
production error is made, mass media publicity should be encour-
aged to warn potential users of the drugs. As shown by Sturken-
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boom et al. not all users of a drug can be warned by health profes-
sionals [14]. 
We did find the scientific and medical literature (formal publica-
tions) to be the most important source of both ideas and informa-
tion. The medical journalists in our study indicated to prefer
indirect contact with the professional community provided
through journals, partly because of the peer review system the
journals use, which gives the journalists some guarantee of reliable
results and conclusions. Moreover, these journalists are well aware
of the fact that information about medicines might create false
hopes so if they feel uncertain information is checked by seeking
advice from relevant experts. However, as stated before, the sys-
tem of peer review is not completely waterproof. Journalists must
be able to assume that a peer reviewed published paper is reliable
and based on sound scientific experiments.
Good news, bad news?
The criticism that bad news is more newsworthy than good news,
cannot be confirmed in our study. On the contrary good news
about medicines received more attention in newspapers than bad
news. In the scientific and medical community, studies showing
any (adverse) effects are more often submitted and accepted for
publication than studies showing no (adverse) effects; this is called
publication bias. As already shown by Koren et al. this publication
trend seems to be reinforced by the way newspaper journalists se-
lect their topics. Journalists prefer to write articles about studies
showing (adverse) effects [36]. This thesis shows that on top of
that, newspaper journalists introduce an extra form of bias by
focussing on good news. 
Another concern of the scientific community - i.e that the media
does not portray  current developments and concerns within the
scientific community - seems not to apply completely for news
about medicines. In fact, our study dealing with agenda setting
suggests that the newspapers pay attention to the same topics -
therapeutic groups of medicines - as the professional literature. If
therefore some diseases or pharmaceuticals receive more attention
than others in mass media reporting this can be partly explained
by the preoccupation of the professional journals. However, the
mass media do pay more attention to "good" news than to "bad"
news on medicines. With respect to this point, it seems true that
the way in which the mass media portray therapeutic develop-
ments is too optimistically; the publication bias as found in the sci-
entific journals is reinforced. Journalists writing about scientific
developments are dependent on their sources. Both researchers
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and pharmaceutical companies are eager to promote their stories
of success. Nelkin argues that the press coverage of new techno-
logical developments probably encourages the public desire for
easy solutions to economic, social and medical problems. Just as
high technology is presented as the solution to international com-
petition, so medical technologies are portrayed as solutions to
problems of health. Nelkin states that the press focused exten-
sively on the search for a AIDS vaccine well before this technologi-
cal solution was in sight, helping to divert public attention from
the more immediate need to prevent the transmission of the dis-
ease [37]. Both scientists and journalists should be aware of this
kind of effect of mass media publicity and should portray scientific
research in a more realistic way. Journalists and scientists should
pay more attention to the process of scientific research, and to its
"failures" and pitfalls.
Health education through the mass media?
Some of the forms of criticism are also related to differences in
opinions about the role the mass media should serve. Especially
health educators think that mass media journalists should have a
responsibility and a role in patient education and counselling.
Therefore, they are very concerned with the lack of practical infor-
mation and the fact that some diseases are underreported in the
mass media. Winnubst showed that science journalists do think
they have a task informing a general public about developments in
science and to provide their audience with practical information
about these developments. Science journalists, however, are
autonomous in the selection of topics. They are guided by latest
trends in science, not by the needs of health educators. Family
magazines, on the other hand, do provide their readers with prac-
tical information on several topics; health educators could try to
co-operate with family magazines. This kind of co-operation has,
in our opinion, several advantages. Family magazines do play a
major role as an information source for the general public on
health topics. Furthermore, they do know how to deal with a
topic. Health educators could provide journalists with important
information on a topic that needs attention. 
Both our studies concerned with information about medicines
in family magazines (chapter 6) and medicines in relation to preg-
nancy (annex 1) show that the reader’s do get practical informa-
tion about medicines. The question and answers sections of these
magazines are specially designed to "educate" the readers. How-
ever, we agree with the criticism of Freimuth about risk informa-
tion [38]. Although the public wants to know about side effects of
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medicines [39,40], this information is given in less than half of all
the publications in family magazines. If family magazines wish to
assume a degree of responsibility in patient education they should
pay attention to the side effects of drugs in all articles. Magazines
could play a major role in health education, since the editors do
know their audience very well. They know the needs, perceptions
and language of their readers and are, therefore, in a position to
pass on health messages in an effective way to a large audience.
Their audience is, in fact, very interested in health related informa-
tion. The pharmaceutical industry is well aware of the potential of
this communication channel and is already using it. Health educa-
tors could try to cooperate with these magazines in a similar way,
instead of wasting money to produce yet further brochures.  
7.6 CAN THE MASS MEDIA BE CONSIDERED A GOOD
CHANNEL IN OPTIMIZING RATIONAL DRUG USE? Mass Media as channel for optimizing Rational Drug use
Increasingly, the general public wants to be promptly informed ofnew medical and scientific findings. Elie showed in a pilot study
that news about new cures results in a small increase in physician
consultations [41]. This puts pressure more than ever on all of us
engaged in biomedical research to be clear, accurate, and honest
and not to overstate our findings [42]. Several articles have been
written about the way to interact with the media with special focus
on physicians and other health professionals [43-45]. Special meet-
ings have been organized to stimulate a discussion between
healthcare professionals and mass media journalists [13,46] and to
make a fruitful cooperation with respect to medical news possible.
Both the scientific and medical community on one hand, and
the mass media journalist on the other, are responsible for what is
published in the lay press about medicines. Sources, like the scien-
tific and medical community, influence the news by decisions
about what they tell and what they do not tell and their timing of
bringing news. Recently, some researchers in the Netherlands
wrote a fake book about the latest developments in medicine. All
the articles in this book were invented by the authors [47]. They
wanted to "check" whether or not the medical community and
journalists were able to discover that all of it was nonsense. In fact
at least one journalist called the editor of the book to check some
of the information. However, this editor did not disillusion him.
This shows that it is the duty of the journalist to check information
on medicines with a relevant expert, since we all know that infor-
mation in the lay press about (promising) new cures can create
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false hopes. Journalists should in all cases consult relevant experts.
On the other hand, if a relevant expert is asked for advice by a
journalist it is his duty to cooperate in the best way he can to pre-
vent mistakes being made. If an expert is asked for advice on
something he is not an expert on, he should make that clear to a
journalist. Both scientists and journalists should not portray scien-
tific research on drugs in a too optimistical way; the picture that
drugs will solve all the health problems is not a very realistic pic-
ture. This picture could be, or is perhaps already, created by focus-
ing mainly on positive effects of medicines.
In the last three decades people have become more involved in
their health and illness. The access to relevant and new informa-
tion about disease, their causes and treatment is of major impor-
tance in this emancipation process. Newspapers and family
magazines do play a role in the provision of information about
drugs to a general public. The provision of information about the
latest trends with respect to drugs is important in the general edu-
cation of the public. Secondly, because this kind of information
might be directly applicable in one’s own situation - it might influ-
ence a decision whether or not to use a particular drug, or to visit a
physician. Thirdly, because it allows people to make up their own
minds about political discussions in this field. On the other hand,
information about medicine in the public media causing disease
awareness and interest in certain issues is one of the factors influ-
encing the "medicalization" process. This is especially relevant,
since journalists use the professional medical literature as a source
of ideas and information, and the two processes might enhance
each other. Both health professionals and the general public might
get the same sort of information at the same time. 
In this thesis information about drugs in newspapers and family
magazines was studied. Further research is necessary to study the
role of journalists working in television, free local papers, and gos-
sip papers, and the kind of information about drugs provided to a
general public through these channels. The impact of information
in the mass media on drug utilization merits attention as well. The
development and validation of research methods in this field also
needs attention. In general, the combination of a quantitative and
qualitative approach could be used more often in this field of re-
search. As shown in this thesis, the different research approaches,
provide us with complementary information and have been very
useful in understanding the process of making news about medi-
cines.
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The communication power of both newspapers and family
magazines is potentially enormous. The pharmaceutical indus-
try is well aware of this fact. Both newspapers and magazine
editors know their readers, and can be, therefore, more often
asked to be helpful in designing and implementing health edu-
cation campaigns. In articles  about (new) medicines attention
should be paid to side effects. Furthermore, these channels play
an important role informing people about newly discovered se-
rious side effects of drugs. 
Information provided by mass media journalists is partially in
accordance with the professional literature. The scientific com-
munity and health professionals are the most important sources
of ideas and information. Nevertheless, the information about
medicines in newspapers and magazines is biased. Both news-
papers and magazines do pay more attention to "good news"
than "bad news" on medicines.
Scientists and health professionals as well as journalists should
not portray news on medicines in a too optimistical way. The
picture that drugs will solve all the health problems could be, or
is perhaps already, created by focussing mainly on positive ef-
fects of medicines.
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